Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

[Chemotherapy, chemoradiotherapy or observation after complete resection of pancreatic adenocarcinoma?].

Lluís F.

Gastroenterol Hepatol. 2009 Feb;32(2):120-1. doi: 10.1016/j.gastrohep.2008.10.003. Epub 2009 Feb 5. Spanish. No abstract available.

PMID:
19231687
2.

[Chemoradiation for pancreatic adenocarcinoma].

Flandin I, Mornex F, Claude L, Kubas A, Khodri M, Wautot V, Mazeron R, Partensky C.

Cancer Radiother. 2004 Nov;8 Suppl 1:S80-7. Review. French.

PMID:
15679252
3.

Management of a patient with borderline resectable pancreatic cancer. Case report and review.

Shah AP, Strauss JB, Leslie WT, Shah A, Mahon B, Abrams RA.

Oncology (Williston Park). 2008 Nov 30;22(13):1524-9. Review.

4.

Neoadjuvant chemoradiation to convert locally advanced pancreatic body adenocarcinoma to resectable disease.

Cunningham SC, Cusnir M, Burdick RK, Van Echo DA, Moesinger R.

Clin Adv Hematol Oncol. 2003 Dec;1(12):741-2; discussion 743. No abstract available.

PMID:
16258479
5.

[Chemotherapy, combined radiochemotherapy and new therapeutic approaches in adenocarcinoma of the pancreas].

André T, Balosso J.

J Chir (Paris). 1999 Dec;136(6):309-17. Review. French.

PMID:
10675820
6.

[Radically resected pancreatic cancer and adjuvant treatment. A review of the literature].

Drudi F, Tassinari D, Giuliani J, Ridolfi C, Gianni L, Tamburini E, Fantini M, Santelmo C, Barzotti E, Lotti N, Ravaioli A.

Recenti Prog Med. 2013 Feb;104(2):80-5. doi: 10.1701/1241.13711. Review. Italian.

PMID:
23535964
7.

Radiotherapy in the adjuvant management of pancreatic adenocarcinoma.

Abrams RA.

Semin Oncol. 2005 Dec;32(6 Suppl 9):S30-2. Review.

PMID:
16399427
8.

[Concomitant chemoradiotherapy and preoperative radiotherapy in exocrine pancreatic adenocarcinoma].

Mornex F, Gérard JP, Chauffert B, Brun M.

Ann Chir. 2000 Feb;125(2):111-7. Review. French.

PMID:
10998795
9.

Adenocarcinoma of the pancreas: the rationale for neoadjuvant therapy.

Sperti C, Pasquali C, Pastorelli D, Ferronato A, Decet G, Pedrazzoli S.

Acta Biomed. 2003;74 Suppl 2:91-5. Review.

PMID:
15055044
10.

Adjuvant therapy for surgically resected pancreatic adenocarcinoma.

Abbruzzese JL.

JAMA. 2008 Mar 5;299(9):1066-7. doi: 10.1001/jama.299.9.1066. No abstract available.

PMID:
18319419
11.

Adjuvant and neoadjuvant therapy in curable pancreatic cancer.

Nugent FW, Stuart K.

Surg Clin North Am. 2010 Apr;90(2):323-39. doi: 10.1016/j.suc.2009.12.010. Review.

PMID:
20362789
12.

The recent past and future of adjuvant therapy for pancreatic cancer.

Yeo CJ.

Ann Surg Oncol. 2003 Jun;10(5):488-9. No abstract available.

PMID:
12794012
13.

Adjuvant therapy for pancreatic cancer: to treat or not to treat?

Berlin JD.

Oncology (Williston Park). 2007 May;21(6):712-8; discussion 720, 725-6, 730. Review.

14.

Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration.

Breslin TM, Hess KR, Harbison DB, Jean ME, Cleary KR, Dackiw AP, Wolff RA, Abbruzzese JL, Janjan NA, Crane CH, Vauthey JN, Lee JE, Pisters PW, Evans DB.

Ann Surg Oncol. 2001 Mar;8(2):123-32.

PMID:
11258776
15.

Adjuvant treatment for resectable pancreatic cancer.

Chua YJ, Cunningham D.

J Clin Oncol. 2005 Jul 10;23(20):4532-7. Review.

PMID:
16002844
16.

The feasibility and safety of immunotherapy with dendritic cells loaded with CEA mRNA following neoadjuvant chemoradiotherapy and resection of pancreatic cancer.

Morse MA, Nair SK, Boczkowski D, Tyler D, Hurwitz HI, Proia A, Clay TM, Schlom J, Gilboa E, Lyerly HK.

Int J Gastrointest Cancer. 2002;32(1):1-6.

PMID:
12630764
17.

Successful resection of advanced pancreatic tail cancer after neoadjuvant gemcitabine chemotherapy: report of a case.

Matsuda T, Taniguchi F, Minato H, Nomura H, Tsuda T, Aikawa I.

Surg Today. 2006;36(8):754-7.

PMID:
16865525
18.

Neoadjuvant treatment of oesophageal adenocarcinoma.

Robb WB, Naughton P, Walsh TN.

Minerva Chir. 2004 Oct;59(5):461-70. Review.

19.

Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial.

Le Scodan R, Mornex F, Partensky C, Mercier C, Valette PJ, Ychou M, Roy P, Scoazec JY.

Am J Clin Oncol. 2008 Dec;31(6):545-52. doi: 10.1097/COC.0b013e318172d5c5.

PMID:
19060585
20.

[Long term survival after pancreatic resection for pancreatic adenocarcinoma].

Wirtz M, Friess H.

Z Gastroenterol. 2002 Sep;40(9):849-52. German. No abstract available.

PMID:
12215954

Supplemental Content

Support Center